Hodnota podniku společnosti 180 Life Sciences
Jaká je hodnota metriky Hodnota podniku společnosti 180 Life Sciences?
Hodnota metriky Hodnota podniku společnosti 180 Life Sciences Corp. je $8.60M
Jaká je definice metriky Hodnota podniku?
Podniková hodnota (Enterprise value) je měřítkem celkové tržní hodnoty společnosti. Vypočítává se jako tržní kapitalizace s dluhem, menšinovým podílem a přednostními akciemi sníženými o celkovou hodnotu dostupných peněz a jejich ekvivalentů.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Hodnota podniku společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností 180 Life Sciences
Čemu se věnuje společnost 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Firmy s metrikou hodnota podniku podobnou společnosti 180 Life Sciences
- Hodnota metriky Hodnota podniku společnosti Lamtex je $8.57M
- Hodnota metriky Hodnota podniku společnosti Enertime SA je $8.58M
- Hodnota metriky Hodnota podniku společnosti Invex Therapeutics Ltd je $8.58M
- Hodnota metriky Hodnota podniku společnosti Invex Therapeutics Ltd je $8.58M
- Hodnota metriky Hodnota podniku společnosti KalNorth Gold Mines je $8.59M
- Hodnota metriky Hodnota podniku společnosti SportsHero je $8.59M
- Hodnota metriky Hodnota podniku společnosti 180 Life Sciences je $8.60M
- Hodnota metriky Hodnota podniku společnosti IDT Australia je $8.60M
- Hodnota metriky Hodnota podniku společnosti InsuraGuest Technologies je $8.60M
- Hodnota metriky Hodnota podniku společnosti Inventus Mining je $8.60M
- Hodnota metriky Hodnota podniku společnosti Virat Crane Industries je $8.60M
- Hodnota metriky Hodnota podniku společnosti Black Swan Graphene Inc je $8.60M
- Hodnota metriky Hodnota podniku společnosti QMC Quantum Minerals Corp je $8.61M